Upstream Bio (UPB) Interest & Investment Income (2023 - 2026)

Upstream Bio's Interest & Investment Income history runs 4 years deep, the most recent figure standing at $3.1 million for Q1 2026.

• On a quarterly basis, Interest & Investment Income fell 35.61% year-over-year to $3.1 million in Q1 2026; TTM through Mar 2026 was $10.7 million, a 15.65% decrease from a year earlier, with the FY2025 full-year figure at $16.9 million, up 39.68% from the prior year.
• Interest & Investment Income declined to $3.1 million in Q1 2026 per UPB's latest filing, from $3.7 million in the prior quarter.
• Across five years, Interest & Investment Income topped out at $5.1 million in Q4 2024 and bottomed at -$110000.0 in Q2 2025.
• The 4-year median for Interest & Investment Income is $2.9 million (2024), against an average of $2.4 million.
• Biggest YoY gain for Interest & Investment Income was 11392.86% in 2025; the steepest drop was 223.53% in 2025.
• Year by year, Interest & Investment Income stood at $1.5 million in 2023, then jumped by 234.17% to $5.1 million in 2024, then declined by 28.01% to $3.7 million in 2025, then fell by 16.42% to $3.1 million in 2026.
• Per Business Quant, the three latest UPB Interest & Investment Income figures stand at $3.1 million (Q1 2026), $3.7 million (Q4 2025), and $4.1 million (Q3 2025).